Navigation Links
Synvista Therapeutics to Present at the BIO InvestorForum 2007
Date:10/2/2007

- Presentation To Be Webcast -

MONTVALE, N.J., Oct. 2 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announced today that Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer will present at the BIO InvestorForum 2007 on Thursday, October 11, 2007 at 11:00 a.m. PT. BIO InvestorForum will be held on October 9 - 11, 2007 at the Palace Hotel in San Francisco, CA.

Dr. Berkowitz will discuss the company's planned and/or ongoing Phase 2 initiatives for ALT-2074 in cardiovascular diseases, and alagebrium in heart failure and diabetic nephropathy. He will also provide an update of recent milestones and executive appointments.

The presentation will be simultaneously webcast and can be viewed live on the investor relations section of the Company's web site at http://www.synvista.com. Participants are encouraged to log on to the webcast approximately five to ten minutes prior to the start of the presentation. It will be archived there after the event.

Note to BIO Attendees: Synvista has made additional time available for one-on-one meetings during the conference. If interested, please arrange through BIO or by contacting Lippert/Heilshorn & Associates at 212-838-3777.

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing small molecule drugs to treat and prevent cardiovascular disease and to treat nephropathy in people with diabetes. The Company has identified several product candidates that it believes represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)..., Oct. 13 /PRNewswire-USNewswire/ -- Midwest Resea...of a new Center for,Integrated Algal Research and ...irector of Energy Programs., "Reducing America,s ...foremost challenges -- one in which MRI has been i...velopment and as the Management and Operating,cont...
(Date:10/13/2008)... /- Larry Corey, M.D., senior vice,pr...ous Disease Institute,at Fred Hutchinson Cancer Re...mbers of the prestigious Institutes of Medicine (I...e highest honors in the,fields of health and medic...ed outstanding professional achievement and commit...
(Date:10/13/2008)...en, October 13 /- Mentice, a leading,...unces the appointment of,Mr. Bjorn Larsson as Vice...oday Mr. Bjorn Larsson will head up and coordinate...rporate standpoint., Mr. Larsson brings to Mentic...keting and product management within pharmaceutica...
(Date:10/13/2008)...Oct. 13 /- Proteon Therapeutics is,pr...preclinical,demonstration of the potential of PRT-... lower limb peripheral arterial disease (PAD). The...Elastase Therapy: A Novel,Approach to Vessel Dilat...ual Transcatheter Cardiovascular Therapeutics (TCT...
Breaking Biology Technology:MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position 2Mentice Appoints Bjorn Larsson as Vice President of Global Marketing 2Proteon Therapeutics to Present New Data on PRT-201 at Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium in Washington, D.C., October 13, 2008 2
... ,>O. Rönn 1 , M. Landström 2 , A. Edm... 1 GE Healthcare, Uppsala, Sweden , ... Sweden , , ECL Plex™ Weste...t picogram levels, with linearity over 3.6 orders ...neously, and differential quantitation of low-abun...
...Introduction , High-throughput screening f...g development and a key application is in the area...upled receptors (GPCRs) (1). , <P ,>It i...han GPCRs of potential therapeutic value requiring...The Sigma-RBI Library of Pharmacologically Active ...
... 77, TE 70 PWR, TE 77 PWR , ECL™ Sem... electrophoretic transfer results using low curren..., • Units available with and withou...ity , • Complete, uniform electr...less than 1 h , • Minimal buffe...
... Key words: adenoviral vector • viral ...bull; gene delivery, , Biological ... greatly aid secondary screening as well as lead a...ts several challenges. Establishing stable cell sy...table levels is time-consuming. In addition, cellu...
Other Biology Technology:Detection and quantitation of low-abundant proteins with ECL Plex fluorescent Western blotting 2Detection and quantitation of low-abundant proteins with ECL Plex fluorescent Western blotting 3Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 2Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 3Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 4Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 5Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 6ECL Semi-dry Blotters 2Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 2Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 3Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 4Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 5Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 6Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 7Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 8Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 9Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 10
(Date:10/13/2008)...syth Institute, working with collaborators at Tuft...w control over embryonic stem cells, behavior. The...hanism within frog embryonic stem cells and trigge... growth, change in cell shape, and invasion of the...rical signals are a powerful control mechanism tha...
(Date:10/13/2008)...African chimpanzees living in Cte d,Ivoire, resear... dropped in numbers by a whopping 90 percent since...ew remaining chimpanzees are now highly fragmented...ional Park, according to a report in the October 1...cation. , This alarming decline in a country tha...
(Date:10/13/2008)...y different parts of the brain can come under atta...ding to a new study in mice with an MS-like diseas...nvading T cells dictates whether it,s the spinal c...from researchers at the University of Maryland Sch...sity in St. Louiswill be published online on Octob...
(Date:10/12/2008)...e in French . , Researchers at McGill Univers.... have identified two genetic variants in caucasia...ncrease the risk of male pattern baldness. Their r...ature Genetics. , About a third of all men are ...ondition,s social and economic impact is considera...
Breaking Biology News(10 mins):Forsyth scientists trigger cancer-like response from embryonic stem cells 2In a last 'stronghold' for endangered chimpanzees, survey finds drastic decline 2Researchers discover baldness gene: 1 in 7 men at risk 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 1Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 3Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 4For migrating sparrows kids have a compass but adults have the map 1116 1For migrating sparrows kids have a compass but adults have the map 1116 22007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 12007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 2HealthFitness Announces Third Quarter 2007 Financial Results 5565 1HealthFitness Announces Third Quarter 2007 Financial Results 5565 2HealthFitness Announces Third Quarter 2007 Financial Results 5565 3HealthFitness Announces Third Quarter 2007 Financial Results 5565 4HealthFitness Announces Third Quarter 2007 Financial Results 5565 5HealthFitness Announces Third Quarter 2007 Financial Results 5565 6HealthFitness Announces Third Quarter 2007 Financial Results 5565 7HealthFitness Announces Third Quarter 2007 Financial Results 5565 8HealthFitness Announces Third Quarter 2007 Financial Results 5565 9HealthFitness Announces Third Quarter 2007 Financial Results 5565 10HealthFitness Announces Third Quarter 2007 Financial Results 5565 11HealthFitness Announces Third Quarter 2007 Financial Results 5565 12HealthFitness Announces Third Quarter 2007 Financial Results 5565 13HealthFitness Announces Third Quarter 2007 Financial Results 5565 14HealthFitness Announces Third Quarter 2007 Financial Results 5565 15HealthFitness Announces Third Quarter 2007 Financial Results 5565 16
... Medical Center implanted Artificial Silicon Retin... treat vision loss caused by retinitis pigmentosa ...ameter and one-thousandth of an inch thick, less t...s had surgery Tuesday, January 25. The fifth patie... investigator Dr. John Pollack performed the surge...
...bright, light-emitting molecules have enabled rese...ter below the skin surface using only infrared lig...esearchers based at the University of Pennsylvania...scent materials called porphyrins within the surfa... a tumor within a living rodent. Their findings, w...
... to humane alternatives to the use of animals in r...wn that requires using animals as part of the test... Committee for Responsible Medicine, you invent yo... announced today that PCRM has developed the world...o measure insulin levels in individuals with diabe...
...searchers have identified several genetic changes ... help researchers better understand how and why pe...sue of the Journal of Neuroscience, researchers re...ion patterns regulated by alcohol in two mouse str...fer in a number of behavioral responses to acute a...
Other Biology News:Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss 2Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss 3Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin 2PCRM develops world's first cruelty-free insulin assay 2VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 2VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 3
Source of colony stimulating factors for assays of mouse hematopoietic progenitors from bone marrow, spleen, blood and fetal liver. Suitable for the growth of mouse BFU-E, CFU-M, CFU-G and CFU-GEMM
MagNA Pure LC Instrument from Roche Applied Science
Piperazine-N',N'-bis(2-ethanesulfonic acid), monosodium salt
...the principal excitatory neurotransmitter receptor...st: Ionotropic receptors, and metabotropic recepto...complexes of various subunits (GluR1-7, NMDA1-3, K.... Metabotropic glutamate receptors are G-protein c...
Biology Products: